FeesSafety
Pluang+

InvenTrust Properties posts 6.4% core FFO growth in Q3 2026 with strong occupancy and low debt.

Analyst Insights
29 Oct 2026, 15:10 WIB
Seeking Alpha
View Source
Bullish
InvenTrust Properties posts 6.4% core FFO growth in Q3 2026 with strong occupancy and low debt.

InvenTrust Properties (IVT), a Sunbelt-focused, grocery-anchored retail REIT, reported a 6.4% year-over-year increase in core FFO per share for Q3 2026. The company also showed 11% growth in AFFO and 17.3% growth in free cash flow per share year-to-date, supported by a high leased occupancy rate of 96.4%. IVT maintains the lowest net debt to EBITDA ratio among its peers at 4.9x and has a favorable debt maturity schedule. Despite solid growth and a strong balance sheet, the current valuation of around 15.5 times core FFO limits the margin of safety, leading to a 'Hold' rating from the analyst.

InvenTrust Properties provides context for real estate investors. For readers following US real estate stocks, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: 42 of 47 priced Real Estate-sector US stocks rose today. Notable movers include AMH at USD 31.59 (+1.25%), WELL at USD 229.95 (+1.21%) with 87% buy orders, and DOC at USD 18.76 (+1.13%).

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App